GlassScriptPhysician profile
Wilson Tong
NPI 1427261437
$25,237.89
in general payments reported to CMS, 2019-2025
93 companies · $6,359 in 2025
The $6,359 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,703 · 2020: $1,206 · 2021: $2,588 · 2022: $3,298 · 2023: $3,404 · 2024: $4,679 · 2025: $6,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,193.78 |
| Education | $247.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $2,195.19 | 2019-2023 | Padcev, Tukysa |
| Janssen Biotech, INC. | $1,691.76 | 2019-2025 | Erleada, Akeega, Darzalex |
| Astrazeneca Pharmaceuticals LP | $1,650.82 | 2019-2025 | Imfinzi, Enhertu, Lynparza |
| Merck Sharp & Dohme LLC | $1,646.00 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,267.25 | 2019-2025 | |
| Celgene Corporation | $1,168.60 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $1,059.53 | 2019-2025 | Opdivo |
| Novartis Pharmaceuticals Corporation | $1,030.70 | 2019-2025 | |
| Genentech USA, INC. | $798.15 | 2019-2025 | Polivy, Venclexta, Lunsumio |
| Kite Pharma, INC. | $707.19 | 2020-2024 | Yescarta |
| Amgen INC. | $702.76 | 2019-2023 | Blincyto, Kyprolis, Lumakras |
| Lilly USA, LLC | $592.62 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $565.31 | 2019-2025 | |
| Astellas Pharma US INC | $536.70 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Genzyme Corporation | $462.28 | 2020-2025 |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $447.82 | 2019-2025 | Fruzaqla, Alunbrig, Iclusig |
| Daiichi Sankyo INC. | $437.37 | 2020-2025 | Enhertu, Datroway |
| Array Biopharma INC | $422.59 | 2019-2025 | Mektovi, Braftovi, Tukysa |
| Jazz Pharmaceuticals INC. | $373.38 | 2021-2025 | |
| Glaxosmithkline, LLC. | $355.27 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.80 | 2020-2025 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $262.21 | 2019-2023 | Imbruvica |
| Incyte Corporation | $260.07 | 2020-2025 | Jakafi, Monjuvi, Niktimvo |
| Kyowa Kirin, INC. | $225.83 | 2023-2025 | Poteligeo |
| Aveo Pharmaceuticals, INC. | $224.08 | 2022-2025 | Fotivda |
| Sobi, INC | $220.81 | 2022-2025 | |
| Adc Therapeutics America, INC. | $215.63 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $198.06 | 2022-2025 | Libtayo, Lynozyfic |
| Acrotech Biopharma INC. | $198.04 | 2021-2025 | Beleodaq |
| Exelixis INC. | $196.45 | 2019-2025 | Cabometyx |
| Beigene USA, INC. | $195.86 | 2020-2024 | Brukinsa |
| Karyopharm Therapeutics INC. | $192.53 | 2021-2025 | Xpovio |
| Taiho Oncology, INC. | $178.89 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $171.70 | 2019-2025 | |
| Ethicon INC. | $158.57 | 2022 | |
| Gilead Sciences, INC. | $157.05 | 2019-2025 | Trodelvy |
| Dendreon Pharmaceuticals LLC | $149.52 | 2022-2023 | Provenge |
| Pharmacosmos Therapeutics INC. | $149.05 | 2023-2025 | Monoferric |
| Myovant Sciences INC. | $148.90 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $148.75 | 2024-2025 | Ultomiris |
| Abbvie INC. | $144.06 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $140.42 | 2024-2025 | |
| Stemline Therapeutics INC. | $139.48 | 2024-2025 | Orserdu |
| Springworks Therapeutics, INC. | $138.44 | 2024 | Ogsiveo |
| Rigel Pharmaceuticals, INC. | $135.88 | 2022-2024 | Rezlidhia, Tavalisse |
| Servier Pharmaceuticals LLC | $130.22 | 2022-2025 | |
| Puma Biotechnology, INC. | $111.41 | 2023-2025 | |
| Mirati Therapeutics, INC. | $111.31 | 2023-2024 | Krazati |
| Acera Surgical, INC. | $111.11 | 2024 | Restrata Wound Matrix |
| Emd Serono, INC. | $108.50 | 2021-2025 | |
| Genmab U.S., INC. | $96.93 | 2024-2025 | Epkinly |
| Cti Biopharma Corp. | $96.20 | 2022-2023 | Vonjo |
| Epizyme, INC. | $91.66 | 2020-2021 | |
| Recordati_rare_diseases_inc. | $88.87 | 2025 | Panhematin, Enjaymo, Sylvant |
| Fresenius Kabi USA, LLC | $87.18 | 2024-2025 | Stimufend |
| Tersera Therapeutics LLC | $76.82 | 2022-2025 | Zoladex, Xermelo |
| Pharmaessentia USA Corporation | $70.75 | 2023-2025 | Besremi |
| Janssen Pharmaceuticals, INC | $69.82 | 2019-2022 | |
| Geron Corporation | $68.49 | 2025 | Rytelo |
| Tesaro, INC. | $66.25 | 2019 | |
| Accord Healthcare, INC. | $66.03 | 2023-2024 | |
| Beone Medicines USA, INC. | $58.33 | 2025 | Tevimbra |
| Ipsen Biopharmaceuticals, INC | $57.95 | 2024-2025 | Onivyde, Somatuline Depot |
| Sumitomo Pharma America, INC. | $56.38 | 2023-2025 | Orgovyx |
| Global Blood Therapeutics, INC. | $54.80 | 2022 | |
| Legend Biotech USA INC. | $50.57 | 2025 | Carvykti |
| Coherus Oncology, INC. | $48.49 | 2024-2025 | Loqtorzi |
| Agios Pharmaceuticals, INC. | $46.82 | 2024-2025 | Pyrukynd |
| Invivyd INC | $44.69 | 2024-2025 | Pemgarda |
| Redhill Biopharma INC. | $42.15 | 2021 | |
| Iovance Biotherapeutics, INC. | $40.56 | 2025 | Amtagvi |
| Genentech, INC. | $39.95 | 2019 | |
| Fennec Pharmaceuticals, INC. | $38.29 | 2025 | Fyarro |
| Syndax Pharmaceuticals, INC. | $33.13 | 2025 | |
| Foundation Medicine, INC. | $32.87 | 2022 | |
| Octapharma USA, INC. | $30.00 | 2023 | Octagam Immune Globulin (Human) |
| Spectrum Pharmaceuticals INC. | $29.40 | 2025 | Rolvedon |
| Lexicon Pharmaceuticals, INC. | $27.48 | 2019 | |
| Immunocore Limited | $26.39 | 2025 | Kimmtrak |
| Myriad Genetic Laboratories, INC. | $24.09 | 2023 | Precisetumor |
| Immunogen, INC. | $23.71 | 2023 | Elahere |
| Tactile Systems Technology INC | $23.48 | 2022 | |
| Organon LLC | $22.74 | 2021 | |
| Intuitive Surgical, INC. | $22.73 | 2024 | |
| Biocon Biologics INC | $22.12 | 2025 | Ogivri |
| Apellis Pharmaceuticals, INC. | $19.63 | 2024 | Empaveli |
| Davol INC. | $18.40 | 2020 | |
| Eusa Pharma (US) LLC | $17.90 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.76 | 2021 | |
| Heron Therapeutics, INC. | $17.15 | 2025 | Cinvanti |
| Helsinn Therapeutics (U.S.), INC. | $15.19 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.67 | 2024 | Truxima |
| Clovis Oncology, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
Keytruda $1,115Enhertu $571Lynparza $562Reblozyl $500Tukysa $469Opdivo $453Ibrance $364Lenvima $348Imfinzi $348Erleada $339Xtandi $316Akeega $302Braftovi $299Mektovi $299Kisqali $292Darzalex $291Verzenio $284Calquence $272Tagrisso $268Balversa $254Poteligeo $226Fotivda $210Sarclisa $206Jemperli $203Welireg $196Rybrevant $195Jaypirca $192Epkinly $189Zejula $182Talzenna $181Padcev $177Elrexfio $172Xpovio $165Imbruvica $161Orgovyx $155Polivy $154Monoferric $149Ultomiris $149Libtayo $148Lorbrena $145Venclexta $143Tecvayli $143Ziihera $143Yonsa $140Odomzo $140Orserdu $139Inlyta $139Ogsiveo $138Vonjo $131Cabometyx $130Piqray $123Xalkori $120Jakafi $115Rezlidhia $115Tavalisse $115Comirnaty $114Zepzelca $112Krazati $111Restrata Wound Matrix $111Yescarta $108Ojjaara $105Carvykti $104Brukinsa $103Adcetris $102Monjuvi $101Lunsumio $97.35Mekinist $96.86Fruzaqla $95.87Tecentriq $91.55Beleodaq $91.33Alunbrig $88.82Oxbryta $87.38Inqovi $86.17Lonsurf $86.17Doptelet $83.14Nubeqa $77.58Bosulif $75.10Scemblix $72.87Tibsovo $71.35Besremi $70.75Rytelo $68.49Camcevi $66.03Tecentriq Hybreza $62.52Trodelvy $61.54Tevimbra $58.33Onivyde $57.95Stimufend $57.35Datroway $56.68Fabhalta $56.50Stivarga $55.48Vitrakvi $55.48Xofigo $52.89Iclusig $52.87Panhematin $49.73Elahere $47.50Itovebi $47.12Paxlovid $46.70Provenge $45.87Pemgarda $44.69Zynlonta $44.04
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Tong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.